Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias. Delannoy PY, Boussekey N, Devos P, Alfandari S, Turbelin C, Chiche A, Meybeck A, Georges H, & Leroy O Eur. J. Clin. Microbiol. Infect. Dis., 31:2293-2299, 2012.
Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias [link]Paper  doi  bibtex   
@article{delannoy_py_IMPACT_2012,
title = {Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias},
volume = {31},
issn = {0934-9723},
url = {http://www.ncbi.nlm.nih.gov/pubmed/22350387},
DOI = {10.1007/s10096-012-1568-z},
Language = {English},
Journal = {Eur. J. Clin. Microbiol. Infect. Dis.},
author = {{Delannoy PY} and {Boussekey N} and {Devos P} and {Alfandari S} and {Turbelin C} and {Chiche A} and {Meybeck A} and {Georges H} and {Leroy O}},
year = {2012},
keywords = {Aged, Aminoglycosides/therapeutic use*, Anti-Bacterial Agents/therapeutic use*, Bacteremia/drug therapy*, Cross Infection/drug therapy*, Drug Therapy, Combination/methods, Female, Humans, Intensive Care Units, Male, Middle Aged, Survival Analysis, Treatment Outcome},
pages = {2293-2299}
}

Downloads: 0